Dosage and administration
Wet face. Apply to hands, add water and work into a lather. Massage face gently. Rinse thoroughly.
Wet face. Apply to hands, add water and work into a lather. Massage face gently. Rinse thoroughly.
Store at Room Temperature.
Drug Facts
Salicylic Acid 1%
Acne treatment
For the treatment of acne.
For external use only.
When using this product
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Store at Room Temperature.
Water, cetyl alcohol, glycerin, sucrose cocoate, hydroxypropyl starch phosphate, coco-glucoside, potassium cetyl phosphate, xanthan gum, sodium benzoate, fragrance, menthol, citric acid, sodium phytate, butylene glycol, cedrus atlantica bark extract, portulaca oleracea extract
Visit
www.NeutrogenaNaturals.com or call toll-free 800-582-4048 or 215-273-8755 (collect).
Dist. by Neutrogena Corp.
Los Angeles, CA 90045
NEW INFO
Neutrogena®
naturals
NO
harsh chemical
sulfates, parabens,
petrolatum, dyes,
phthalates
Acne
Cream Cleanser
Clinically proven acne medicine
treats and helps prevent breakouts
Fortified with Wintergreen leaf
derived acne-fighting bionutrient
for clear, healthy-looking skin
DERMATOLOGIST RECOMMENDED BRAND
SALICYLIC ACID ACNE TREATMENT
93% naturally derived
5 FL. OZ. (147 mL)

| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Salicylic Acid | ACTIVE INGREDIENT | O414PZ4LPZ | 2 | |
| Salicylic Acid | ACTIVE MOIETY | O414PZ4LPZ | 2 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| Cedrus Atlantica Bark | INACTIVE INGREDIENT | ITP1Q41UPF | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| Coco Glucoside | INACTIVE INGREDIENT | ICS790225B | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Menthol, Unspecified Form | INACTIVE INGREDIENT | L7T10EIP3A | 2 | |
| Phytate Sodium | INACTIVE INGREDIENT | 88496G1ERL | 2 | |
| Potassium Cetyl Phosphate | INACTIVE INGREDIENT | 03KCY6P7UT | 2 | |
| Purslane | INACTIVE INGREDIENT | M6S840WXG5 | 2 | |
| Sodium Benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 2 | |
| Sucrose Cocoate | INACTIVE INGREDIENT | 3H18P0UK73 | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10812-034 | 10812-034-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Salicylic Acid | O414PZ4LPZ | ACTIB |
| Water | 059QF0KO0R | IACT |
| Cetyl Alcohol | 936JST6JCN | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Sucrose Cocoate | 3H18P0UK73 | IACT |
| Coco Glucoside | ICS790225B | IACT |
| Potassium Cetyl Phosphate | 03KCY6P7UT | IACT |
| Xanthan Gum | TTV12P4NEE | IACT |
| Sodium Benzoate | OJ245FE5EU | IACT |
| Menthol, Unspecified Form | L7T10EIP3A | IACT |
| Citric Acid Monohydrate | 2968PHW8QP | IACT |
| Phytate Sodium | 88496G1ERL | IACT |
| Butylene Glycol | 3XUS85K0RA | IACT |
| Cedrus Atlantica Bark | ITP1Q41UPF | IACT |
| Purslane | M6S840WXG5 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAMUSCULAR | 864 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION, EXTENDED RELEASE / ORAL | 186.8 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION/ DROPS / ORAL | 22 mg | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | PASTE, DENTIFRICE / DENTAL | 4.7 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | GEL / TOPICAL | 5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | LOZENGE / ORAL | 1264 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SYSTEM / TOPICAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SPONGE / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | SYRUP / ORAL | 7.5 mg/5ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ec21bb43-07e9-4ed6-b29d-4af2788676aa | 54fa1667-9eae-412f-8ec4-ae9033d3cc79 | 2019-12-06 | Warnings | 54fa1667-9eae-412f-8ec4-ae9033d3cc79 |
Adverse event summaries are temporarily unavailable. Other product information remains available.